• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Target therapy for high grade glioma by using specific antibody against glioma stem cell

Research Project

Project/Area Number 26462187
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Neurosurgery
Research InstitutionSapporo Medical University

Principal Investigator

Wanibuchi Masahiko  札幌医科大学, 医学部, 准教授 (30343388)

Co-Investigator(Kenkyū-buntansha) 山口 美樹  札幌医科大学, 医学部, 助教 (10530454)
鳥越 俊彦  札幌医科大学, 医学部, 教授 (20301400)
佐々木 祐典  札幌医科大学, 医学部, 講師 (20538136)
三國 信啓  札幌医科大学, 医学部, 教授 (60314217)
大瀧 隼也  札幌医科大学, 医学部, 研究員 (20724082)
能代 将平  札幌医科大学, 医学部, 研究員 (90749425)
Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords脳腫瘍 / 神経膠腫 / 膠芽腫 / ACTC1 / IL13R alpha 2 / 予後 / 浸潤 / 細胞骨格 / 分子標的
Outline of Final Research Achievements

Target molecules for therapy of gliomas were identified in our study. Actin, alpha cardiac muscle 1 (ACTC1) which was a part of cytoskeletons became a marker of poor prognosis of gliomas. In glioblastoma which median survival was only one year, the difference of overall survival was over two years by presence or absence of ACTC1.ACTC1 was also related to the tumor invasion in high grade gliomas. These results were presented on Journal of Neurosurgery 2017 which was one on top journals in the field of neurosurgery. In addition, interleukin 13 receptor alpha 2 was also related to the poor prognosis in high grade gliomas. This identification will be on Journal of Neurosurgical Sciences in 2017.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report
  • Research Products

    (5 results)

All 2017 2016 Other

All Int'l Joint Research (2 results) Journal Article (2 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 2 results,  Acknowledgement Compliant: 2 results) Presentation (1 results)

  • [Int'l Joint Research] Yale University School of Medicine(米国)

    • Related Report
      2016 Annual Research Report
  • [Int'l Joint Research] Yale University(米国)

    • Related Report
      2015 Research-status Report
  • [Journal Article] Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas.2017

    • Author(s)
      Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Otsuka Y, Yamaguchi M, Ohnishi H, Ohtaki S, Noshiro S, Ookawa S, Mikami T, Mikuni N, Honmou O
    • Journal Title

      J Neurosurg Sci.

      Volume: 印刷中 Issue: 3

    • DOI

      10.23736/s0390-5616.16.03793-0

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
  • [Journal Article] ACTC1 as an invasion and prognosis marker in glioma.2017

    • Author(s)
      Ohtaki S, Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Noshiro S, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O
    • Journal Title

      J Neurosurg.

      Volume: 126 Issue: 2 Pages: 467-475

    • DOI

      10.3171/2016.1.jns152075

    • Related Report
      2016 Annual Research Report 2015 Research-status Report
    • Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
  • [Presentation] 悪性グリオーマの浸潤因子解析2016

    • Author(s)
      鰐渕昌彦
    • Organizer
      第21回日本脳腫瘍の外科学会
    • Place of Presentation
      虎ノ門ヒルズフォーラム(東京都港区)
    • Year and Date
      2016-09-09
    • Related Report
      2016 Annual Research Report

URL: 

Published: 2014-04-04   Modified: 2022-02-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi